Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate
about
Neuropsychologic sequelae in the long-term survivors of childhood acute lymphoblastic leukemiaPrevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexateReading impairment in a patient with missing arcuate fasciculus.Diffusion-weighted MRI in neuro-oncology.Methotrexate treatment protocols and the central nervous system: significant cure with significant neurotoxicity.White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings.Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials.Quantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia.Reversible posterior leukoencephalopathy in an HIV-infected patient with thrombotic thrombocytopenic purpura.Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants.Pseudoprogression after high-dose busulfan-thiotepa with autologous stem cell transplantation and radiation therapy in children with brain tumors: Impact on survival.Quantitative MRI assessment of leukoencephalopathyComputer-aided detection of therapy-induced leukoencephalopathy in pediatric acute lymphoblastic leukemia patients treated with intravenous high-dose methotrexate.A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation.Improving the segmentation of therapy-induced leukoencephalopathy in children with acute lymphoblastic leukemia using a priori information and a gradient magnitude threshold.Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies.Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate.Magnetic resonance imaging and neurological evaluation after treatment with high-dose methotrexate for acute lymphocytic leukaemia in young children.MR perfusion, diffusion and BOLD imaging of methotrexate-exposed swine brain.Subacute leukencephalopathy after low-dose intrathecal methotrexate in an adolescent heterozygous for the MTHFR C677T polymorphism.Relapsing tumefactive lesion in an adult with medulloblastoma previously treated with chemoradiotherapy and stem cell transplant.Chemotherapy-induced toxic leukoencephalopathy causes a wide range of symptoms: a series of four autopsies.Neuroradiology of chemotherapeutic. Neurotoxicity in children.Coexistence of life threatening chemotherapy related leukoencephalopathy, saggital sinus thrombosis and multiple organ failure in a child with acute lymphoblastic leukemia: an unusual case with clinical recovery.Brain atrophy in children undergoing systemic chemotherapy for extracranial solid tumors.Lesions of the central nervous system in leukemia: Pathological and magnetic resonance imaging features at presentation in 14 patients.A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer.Diffusion-weighted imaging characteristics of methotrexate-induced acute encephalopathy.
P2860
Q28143926-170D71B7-A6D5-4EF2-84D5-5775519F039CQ28250460-22CB610D-DE92-4601-A5F8-4EBA8C9985C6Q30487142-A34301D8-8524-4C5C-8307-ABA20E911330Q30838362-5A0A831E-5517-4368-B970-4F4B09C04993Q31444671-5BAF0F82-E74A-4A3F-BA27-8992D8E6D183Q31541956-3ABFB28C-8149-45B0-B352-23228375E1BBQ32161585-535286DB-672C-4881-996D-5244BCECEA2EQ33291796-91C1BB36-2518-4365-A9BF-FB280B8CCA29Q33344647-3A4F005F-4E66-4C8A-AAAB-BD28A913C30BQ34592925-26AC9996-AE9A-4AA9-8610-0F017930F75EQ36344743-A3F1AB19-4E2E-449E-92AF-5D8FAF110313Q36676853-25410A18-630D-48EB-BAE6-F513B4723A09Q36677457-62664C82-6EFB-450C-89DC-8983CF721DEBQ36677590-BA38EF88-830A-41AF-A395-8638E0A2EFEDQ36677598-C927BE30-5932-4F01-A9E5-B3CC31DD2B35Q37627699-E1C287AC-6A45-44DF-BE6E-04A00F6631D5Q39615014-79D1D287-7562-4726-A075-0AE5A3C41962Q41787986-ED24E3C4-3F8B-4B13-810E-CF4A4A8D0856Q42554970-6EA7E02F-EC89-473E-8342-6E0B9ADDF90CQ43984753-03BD8B9F-58DB-4356-8FC0-53DFD9956676Q44212687-DB9EE1E2-16C5-446E-9A07-1C96BAD2004FQ46017414-12FE7B06-2996-47AF-A55C-7A90320D0C2CQ48101972-3EEB17EA-8C9A-42FB-9EB8-580271758886Q48254281-0369F3EC-C862-467A-B665-FCC6BDACEE0BQ48662837-7065AF47-28BE-48EF-8BD5-AB0944196D18Q48794898-9009DEB5-AED1-4216-A9BB-405969139B7FQ49210894-6C6A7ECD-6631-4D8A-965C-0CE75707FF94Q51985547-00C9DEEA-21F2-4ACE-8EF5-B0A680B878E8Q55315263-609541D5-3C89-49D6-ACFA-38BF6AE053DC
P2860
Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Nuclear magnetic resonance abn ...... with intrathecal methotrexate
@ast
Nuclear magnetic resonance abn ...... with intrathecal methotrexate
@en
Nuclear magnetic resonance abn ...... with intrathecal methotrexate
@nl
type
label
Nuclear magnetic resonance abn ...... with intrathecal methotrexate
@ast
Nuclear magnetic resonance abn ...... with intrathecal methotrexate
@en
Nuclear magnetic resonance abn ...... with intrathecal methotrexate
@nl
prefLabel
Nuclear magnetic resonance abn ...... with intrathecal methotrexate
@ast
Nuclear magnetic resonance abn ...... with intrathecal methotrexate
@en
Nuclear magnetic resonance abn ...... with intrathecal methotrexate
@nl
P2093
P2860
P1433
P1476
Nuclear magnetic resonance abn ...... with intrathecal methotrexate
@en
P2093
P2860
P304
P356
10.1002/1097-0142(19921001)70:7<1997::AID-CNCR2820700732>3.0.CO;2-G
P407
P577
1992-10-01T00:00:00Z